0000899243-20-006984.txt : 20200304
0000899243-20-006984.hdr.sgml : 20200304
20200304174256
ACCESSION NUMBER: 0000899243-20-006984
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200302
FILED AS OF DATE: 20200304
DATE AS OF CHANGE: 20200304
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GIANAKAKOS ANASTASIOS
CENTRAL INDEX KEY: 0001413822
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37609
FILM NUMBER: 20688559
MAIL ADDRESS:
STREET 1: 333 ALLERTON AVE.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MyoKardia, Inc.
CENTRAL INDEX KEY: 0001552451
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 455500552
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1000 SIERRA POINT PARKWAY
CITY: BRISBANE
STATE: CA
ZIP: 94005
BUSINESS PHONE: 650-741-0900
MAIL ADDRESS:
STREET 1: 1000 SIERRA POINT PARKWAY
CITY: BRISBANE
STATE: CA
ZIP: 94005
FORMER COMPANY:
FORMER CONFORMED NAME: MyoKardia Inc
DATE OF NAME CHANGE: 20120618
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-03-02
0
0001552451
MyoKardia, Inc.
MYOK
0001413822
GIANAKAKOS ANASTASIOS
C/O MYOKARDIA, INC.
1000 SIERRA POINT PARKWAY
BRISBANE
CA
94005
1
1
0
0
President and CEO
Common Stock
2020-03-02
4
S
0
1108
63.3993
D
85688
D
Common Stock
2020-03-02
4
S
0
2070
64.3492
D
83618
D
Common Stock
2020-03-02
4
S
0
1800
65.192
D
81818
D
Common Stock
2020-03-02
4
S
0
22
65.97
D
81796
D
Common Stock
225947
I
By Reporting Person's Trust 2
Common Stock
323526
I
By Reporting Person's Trust 3
Common Stock
12200
I
By Trust 1
Common Stock
12200
I
By Trust 2
Common Stock
12200
I
By Trust 3
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
Represents the weighted average sale price of the shares sold ranging from $62.77 to $63.76 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the ranges reported in footnotes 2 through 4.
Represents the weighted average sale price of the shares sold ranging from $63.80 to $64.74 per share.
Represents the weighted average sale price of the shares sold ranging from $64.89 to $65.82 per share.
/s/ Jacob Bauer, as Attorney-in-Fact
2020-03-04